You are here

  • Home
  • Archive
  • Volume 69, Issue 5
  • Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer

Article info

Article menu

This article has a correction. Please see:

Download PDFPDF
Pancreas
Original research
Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer

Authors

  • Chen Liang Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China Pancreatic Cancer Institute, Fudan University, Shanghai, China PubMed articlesGoogle scholar articles
  • Si Shi Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China Pancreatic Cancer Institute, Fudan University, Shanghai, China PubMed articlesGoogle scholar articles
  • Yi Qin Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China Pancreatic Cancer Institute, Fudan University, Shanghai, China PubMed articlesGoogle scholar articles
  • Qingcai Meng Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China Pancreatic Cancer Institute, Fudan University, Shanghai, China PubMed articlesGoogle scholar articles
  • Jie Hua Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China Pancreatic Cancer Institute, Fudan University, Shanghai, China PubMed articlesGoogle scholar articles
  • Qiangshen Hu Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China Pancreatic Cancer Institute, Fudan University, Shanghai, China PubMed articlesGoogle scholar articles
  • Shunrong Ji Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China Pancreatic Cancer Institute, Fudan University, Shanghai, China PubMed articlesGoogle scholar articles
  • Bo Zhang Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China Pancreatic Cancer Institute, Fudan University, Shanghai, China PubMed articlesGoogle scholar articles
  • Jin Xu Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China Pancreatic Cancer Institute, Fudan University, Shanghai, China PubMed articlesGoogle scholar articles
  • Xian-Jun Yu Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China Pancreatic Cancer Institute, Fudan University, Shanghai, China PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Xian-Jun Yu, Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China; yuxianjun88{at}hotmail.com
View Full Text

Citation

Liang C, Shi S, Qin Y, et al
Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer
Gut 2020;69:888-900.

Publication history

  • Received July 10, 2018
  • Revised August 23, 2019
  • Accepted September 2, 2019
  • First published October 14, 2019.
Online issue publication 
May 18, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.